Nicole hosts Rob Etherington, the CEO of the clinical-stage biopharmaceutical company Clene (CLNN), to discuss the company's latest progress on its treatments for Parkinson's and other neurodegenerative diseases.
The Watch List
04 Mar 2021
SHARE
The Watch List
04 Jan 2022
The Watch List
20 Dec 2021
The Watch List
22 Feb 2022
The Watch List
06 Dec 2021
Trading 360
18 Jan 2022
The Watch List
01 Mar 2022